Musk upgrades to Mounjaro, 'King Kong' of weight-loss medications
Mounjaro, which has been dubbed the "King Kong" of weight-loss drugs, is considered more effective than its competitors with fewer side effects. It received FDA approval for weight loss in November 2023 under the brand name Zepbound. In the UK, the drug will be available on a limited basis through the NHS starting in April.